tetano
Editor, Senior Moderator
ACS Omega
. 2021 Dec 29;7(4):3203-3211.
doi: 10.1021/acsomega.1c04873. eCollection 2022 Feb 1.
Phage Display-Derived Peptide for the Specific Binding of SARS-CoV-2
Fan Yang[SUP] 1 [/SUP], Li Liu[SUP] 2 3 [/SUP], Pierre Fernand Neuenschwander[SUP] 4 [/SUP], Steven Idell[SUP] 4 [/SUP], Ramakrishna Vankayalapati[SUP] 1 [/SUP], Krishan Gopal Jain[SUP] 4 [/SUP], Ke Du[SUP] 2 3 [/SUP], Honglong Ji[SUP] 4 [/SUP], Guohua Yi[SUP] 1 [/SUP]
Affiliations
Abstract
Beginning from the end of 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic swept all over the world and is still afflicting the whole global population. Given that the vaccine-manufacturing ability is limited and the virus can evolve quickly, vaccination alone may not be able to end the pandemic, thus developing fast and accurate diagnoses and effective therapeutics will always be unmet needs. Phage display peptide library has been used in screening antigen-specific peptides for the invention of novel mimic receptors/ligands. Here, we report that a 12-mer phage display peptide library has been screened against the SARS-CoV-2 receptor-binding domain (RBD), and five of the screened peptides show binding ability with the RBD protein by the enzyme-linked immune sorbent assay. The surface plasmon resonance assay further demonstrates that peptide no. 1 can specifically bind to SARS-CoV-2 RBD with a binding affinity constant (K [SUB]d[/SUB]) of 5.8 μM. Transmission electron microscopy coupled with a magnetic bead assay further confirms that the screened peptide can specifically bind the inactivated SARS-CoV-2 virus. This SARS-CoV-2-specific peptide holds great promise as a new bioreceptor/ligand for the rapid and accurate detection of SARS-CoV-2.
. 2021 Dec 29;7(4):3203-3211.
doi: 10.1021/acsomega.1c04873. eCollection 2022 Feb 1.
Phage Display-Derived Peptide for the Specific Binding of SARS-CoV-2
Fan Yang[SUP] 1 [/SUP], Li Liu[SUP] 2 3 [/SUP], Pierre Fernand Neuenschwander[SUP] 4 [/SUP], Steven Idell[SUP] 4 [/SUP], Ramakrishna Vankayalapati[SUP] 1 [/SUP], Krishan Gopal Jain[SUP] 4 [/SUP], Ke Du[SUP] 2 3 [/SUP], Honglong Ji[SUP] 4 [/SUP], Guohua Yi[SUP] 1 [/SUP]
Affiliations
- PMID: 35128233
- PMCID: PMC8751651
- DOI: 10.1021/acsomega.1c04873
Abstract
Beginning from the end of 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic swept all over the world and is still afflicting the whole global population. Given that the vaccine-manufacturing ability is limited and the virus can evolve quickly, vaccination alone may not be able to end the pandemic, thus developing fast and accurate diagnoses and effective therapeutics will always be unmet needs. Phage display peptide library has been used in screening antigen-specific peptides for the invention of novel mimic receptors/ligands. Here, we report that a 12-mer phage display peptide library has been screened against the SARS-CoV-2 receptor-binding domain (RBD), and five of the screened peptides show binding ability with the RBD protein by the enzyme-linked immune sorbent assay. The surface plasmon resonance assay further demonstrates that peptide no. 1 can specifically bind to SARS-CoV-2 RBD with a binding affinity constant (K [SUB]d[/SUB]) of 5.8 μM. Transmission electron microscopy coupled with a magnetic bead assay further confirms that the screened peptide can specifically bind the inactivated SARS-CoV-2 virus. This SARS-CoV-2-specific peptide holds great promise as a new bioreceptor/ligand for the rapid and accurate detection of SARS-CoV-2.